Loading...
Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy
The adoptive transfer of CAR-T cells, which are modified T cells expressing chimeric antigen receptors (CARs), to target B cell maturation antigen (BCMA) has demonstrated impressive results in treating relapsed/refractory multiple myeloma. Although BCMA CAR-T therapy induces certain complications in...
Na minha lista:
| Udgivet i: | Regen Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Japanese Society for Regenerative Medicine
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232090/ https://ncbi.nlm.nih.gov/pubmed/32455157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.reth.2020.03.005 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|